The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Robitussin Medi-Soothers
dextromethorphan hydrobromide, menthol · DEXTROMETHORPHAN HYDROBROMIDE 5 mg/1; MENTHOL, UNSPECIFIED FORM 5 mg/1 · Lozenge · Oral · Haleon US Holdings LLC
NDC 00031-9306-01 · 8 LOZENGE in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of dextromethorphan hydrobromide, menthol (Lozenge)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Haleon US Holdings LLC | DEXTROMETHORPHAN HYDROBROMIDE 5 mg/1; MENTHOL, UNSPECIFIED FORM 5 mg/1 | Jul 15, 2026 | Aug 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Robitussin Medi-Soothers — NDC 00031-9306-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00031930601.
Free to cite with attribution — see how the data is put together.